Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium

Thrombosis and Haemostasis

Volumn 87, Issue 5, 2002, Pages 791-795

  Martinelli, Ida ^a   De Stefano, Valerio ^a   Taioli, Emanuela ^a   Paciaroni, Katia ^a   Rossi, Elena ^a   Mannucci, Pier Mannuccio ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Blood coagulation; Factor V Leiden; Prothrombin mutation; Risk factors

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 5 LEIDEN; PROTEIN C; PROTEIN S; PROTHROMBIN;

ADULT; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING FACTOR 5 DEFICIENCY; CASE CONTROL STUDY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE CARRIER; FEMALE; GENE MUTATION; HETEROZYGOSITY; HIGH RISK PATIENT; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; POSTNATAL CARE; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; PUERPERIUM; RISK FACTOR; THROMBOEMBOLISM; THROMBOPHILIA;

EID: 0036253139     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613085     Document Type: Article

References (33)

1. Deep vein thrombosis during pregnancy and the puerperium: A meta-analysis of the period of risk and the leg of presentation
2. The cumulative incidence of venous thromboembolism during pregnancy and puerperium
3. Thrombotic risk during pregnancy: A population study
4. Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives
5. Incidence and diagnosis of deep vein thrombosis associated with pregnancy
6. Epidemiological observations of thrombo-embolic disease during pregnancy and in the puerperium, in 56,022 women
7. Risk factors in venous thromboembolism
8. Haemostasis and thrombosis in pregnancy
9. A review of the obstetrical aspects of haemostasis
10. Resistance to activated protein C as a basis for venous thrombosis
11. Rapid detection of the prothrombin 20210 A variation by allele-specific PCR
12. Thrombosis during pregnancy and surgery in patients with congenital deficiency of antithrombin III, protein C and protein S
13. Thrombosis and pregnancy in congenital deficiency in ATIII, protein C or protein S: Study of 78 women
14. Thrombotic risk in hereditary antithrombin III, protein C or protein S deficiency. A cooperative, retrospective study
15. Pregnancy in women with thrombophilia: Incidence of thrombosis and pregnancy outcome
16. Genetic susceptibility to pregnancy-related venous thromboembolism: Roles of factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations
17. Risk factors for pregnancy associated venous thromboembolism
18. Activated protein C resistance (factor V Leiden) associated with thrombosis in pregnancy
19. The incidence of the factor V Leiden mutation in an obstetric population and its relationship to deep vein thrombosis
20. Arg506-Gln mutation in factor V and risk of thrombosis during pregnancy
21. Pulmonary embolism and deep venous thrombosis during pregnancy or oral contraceptive use: Prevalence of factor V Leiden
22. Deep vein thrombosis in obstetric patients: Diagnosis and risk factors
23. Prothrombin 20210 G→A, MTHFR C677T mutations in women with venous thromboembolism associated with pregnancy
24. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium
25. Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: Implications for prophylaxis
26. The role of inherited thrombophilia in venous thromboembolism associated with pregnancy
27. Use of antithrombotic agents during pregnancy
28. Safety of withholding heparin in pregnant women with a history of venous thromboembolism
29. Reporting standards in venous disease
30. Validated questionnaire for the identification of previous personal or familial venous thromboembolism
31. Laboratory diagnosis of APC-resistance: A critical evaluation of the test and the development of diagnostic criteria
32. Venous thrombosis during pregnancy: Leg and trimester of presentation
33. Safety of low-molecular-weight heparin in pregnancy: A systematic review